154 related articles for article (PubMed ID: 25363194)
1. Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis.
Kunutsor SK; Apekey TA; Seddoh D
Int J Clin Pract; 2015 Jan; 69(1):136-44. PubMed ID: 25363194
[TBL] [Abstract][Full Text] [Related]
2. Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence.
Kunutsor SK; Apekey TA; Cheung BM
J Hypertens; 2015 Dec; 33(12):2373-81. PubMed ID: 26485462
[TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies.
Liu CF; Zhou WN; Fang NY
Int J Clin Pract; 2012 Jul; 66(7):692-8. PubMed ID: 22698421
[TBL] [Abstract][Full Text] [Related]
4. Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship.
Kunutsor SK; Seddoh D
PLoS One; 2014; 9(4):e96068. PubMed ID: 24781277
[TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis.
Kunutsor SK; Abbasi A; Adler AI
Ann Epidemiol; 2014 Nov; 24(11):809-16. PubMed ID: 25263236
[TBL] [Abstract][Full Text] [Related]
6. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis.
Kunutsor SK; Apekey TA; Van Hemelrijck M; Calori G; Perseghin G
Int J Cancer; 2015 Mar; 136(5):1162-70. PubMed ID: 25043373
[TBL] [Abstract][Full Text] [Related]
7. Leisure-time physical activity and incident metabolic syndrome: a systematic review and dose-response meta-analysis of cohort studies.
Zhang D; Liu X; Liu Y; Sun X; Wang B; Ren Y; Zhao Y; Zhou J; Han C; Yin L; Zhao J; Shi Y; Zhang M; Hu D
Metabolism; 2017 Oct; 75():36-44. PubMed ID: 28927737
[TBL] [Abstract][Full Text] [Related]
8. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
André P; Balkau B; Vol S; Charles MA; Eschwège E;
Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
[TBL] [Abstract][Full Text] [Related]
9. Resting heart rate and risk of metabolic syndrome in adults: a dose-response meta-analysis of observational studies.
Liu X; Luo X; Liu Y; Sun X; Han C; Zhang L; Wang B; Ren Y; Zhao Y; Zhang D; Hu D; Zhang M
Acta Diabetol; 2017 Mar; 54(3):223-235. PubMed ID: 27885415
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
11. Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study.
Yadav D; Lee MY; Kim JY; Ryu H; Huh JH; Bae KS; Ahn SV; Chung CH; Park JT; Koh SB
Yonsei Med J; 2017 Jul; 58(4):763-769. PubMed ID: 28540989
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Ryu S; Chang Y; Woo HY; Yoo SH; Choi NK; Lee WY; Kim I; Song J
Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
[TBL] [Abstract][Full Text] [Related]
13. Gamma-glutamyltransferase and risk of cardiovascular mortality: A dose-response meta-analysis of prospective cohort studies.
Wang J; Zhang D; Huang R; Li X; Huang W
PLoS One; 2017; 12(2):e0172631. PubMed ID: 28231268
[TBL] [Abstract][Full Text] [Related]
14. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Kunutsor SK; Apekey TA; Khan H
Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
[TBL] [Abstract][Full Text] [Related]
15. Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis.
Liu CF; Gu YT; Wang HY; Fang NY
PLoS One; 2012; 7(11):e48878. PubMed ID: 23145005
[TBL] [Abstract][Full Text] [Related]
16. Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis.
Kunutsor SK; Apekey TA; Seddoh D; Walley J
Int J Epidemiol; 2014 Feb; 43(1):187-201. PubMed ID: 24585856
[TBL] [Abstract][Full Text] [Related]
17. Serum vitamin D levels in relation to metabolic syndrome: A systematic review and dose-response meta-analysis of epidemiologic studies.
Hajhashemy Z; Shahdadian F; Moslemi E; Mirenayat FS; Saneei P
Obes Rev; 2021 Jul; 22(7):e13223. PubMed ID: 33829636
[TBL] [Abstract][Full Text] [Related]
18. Sedentary time and the risk of metabolic syndrome: A systematic review and dose-response meta-analysis.
Wu J; Zhang H; Yang L; Shao J; Chen D; Cui N; Tang L; Fu Y; Xue E; Lai C; Ye Z
Obes Rev; 2022 Dec; 23(12):e13510. PubMed ID: 36261077
[TBL] [Abstract][Full Text] [Related]
19. Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studies.
Liu Z; Que S; Ning H; Wang L; Peng T
PLoS One; 2013; 8(12):e80596. PubMed ID: 24324614
[TBL] [Abstract][Full Text] [Related]
20. Association of serum gamma-glutamyltransferase with chronic kidney disease risk: a meta-analysis.
Fan Y; Jin X; Man C; Gong D
Free Radic Res; 2018 Aug; 52(8):819-825. PubMed ID: 30208797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
